| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.98▲ | 1.00▲ | 0.99▲ | 0.95▲ | 1.02▼ |
| MA10 | 1.00▲ | 1.01▼ | 1.03▼ | 0.97▲ | 1.15▼ |
| MA20 | 1.01▲ | 1.04▼ | 1.03▼ | 1.04▼ | 1.35▼ |
| MA50 | 1.08▼ | 1.13▼ | 1.15▼ | 1.20▼ | 1.61▼ |
| MA100 | 1.13▼ | 1.22▼ | 1.24▼ | 1.38▼ | N/A |
| MA200 | 1.23▼ | 1.33▼ | 1.32▼ | 1.49▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.002▼ | 0.002▲ | 0.006▲ | -0.027▼ |
| RSI | 47.923▼ | 45.567▼ | 45.298▼ | 44.920▼ | 40.847▼ |
| STOCH | 19.877▼ | 21.086 | 19.049▼ | 27.133 | 16.152▼ |
| WILL %R | -58.929 | -80.833▼ | -78.226▼ | -61.585 | -84.657▼ |
| CCI | 10.060 | -56.958 | -34.320 | 7.201 | -90.348 |
|
Monday, November 24, 2025 05:38 AM
The results of the study show Gelteq’s gel-based delivery technology can significantly enhance oral bioavailability of the drug, in addition to the broad benefits of the technology in solving drug ...
|
|
Thursday, November 20, 2025 04:45 AM
Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug’s commercial potentialIn September 2025 ...
|
|
Monday, November 10, 2025 05:28 AM
Insiders who bought Sol-Gel Technologies Ltd. (NASDAQ:SLGL) stock lover the last 12 months are probably not as affected by last week’s 14% loss. After taking the recent loss into consideration, the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/11/25 | 1.01 | 1.05 | 0.95 | 1.0075 | 564,583 |
| 24/11/25 | 1.13 | 1.26 | 0.925 | 1.06 | 57,691,415 |
| 21/11/25 | 0.89 | 0.928 | 0.875 | 0.881 | 19,900 |
| 20/11/25 | 0.923 | 0.955 | 0.85 | 0.886 | 84,000 |
| 19/11/25 | 0.90 | 0.95 | 0.88 | 0.912 | 72,700 |
| 18/11/25 | 0.90 | 0.9713 | 0.90 | 0.97 | 26,234 |
| 17/11/25 | 0.98 | 1.0652 | 0.902 | 0.9402 | 58,026 |
| 14/11/25 | 0.97 | 1.03 | 0.97 | 0.998 | 348,900 |
| 13/11/25 | 1.06 | 1.06 | 1.00 | 1.01 | 11,758 |
| 12/11/25 | 1.09 | 1.09 | 1.002 | 1.06 | 13,996 |
|
|
||||
|
|
||||
|
|